Sherwin-Williams earnings jolt puts guidance under the microscope
Sherwin-Williams (SHW) has come under pressure after an earnings release that paired 5.6% year on year fourth quarter revenue growth and an EBITDA beat with full-year EPS guidance that fell short of analyst expectations.
See our latest analysis for Sherwin-Williams.
At a share price of $316.39, Sherwin-Williams has seen softer recent momentum, with a 30-day share price return of 4.1% and a 90-day share price return of 7.0%. The 3-year total shareholder return of 44.8% highlights how longer term holders have experienced a very different journey from the past year’s 1.1% total shareholder return decline.
If recent volatility around earnings has you reassessing your watchlist, this can be a good moment to broaden your search and check out 20 top founder-led companies
With Sherwin-Williams trading at $316.39 and sitting at a reported 4.8% intrinsic discount alongside a 20.8% gap to analyst targets, you need to ask: is there real value here, or has the market already priced in future growth?
Most Popular Narrative: 18.5% Undervalued
Against the last close of $316.39, the most followed narrative sets Sherwin-Williams' fair value at $388.14, anchoring a clear value gap that hinges on execution, capital returns, and rating resets over time.
The company's sustained focus on cost control, broad and deep restructuring (doubling annual savings targets to ~$80 million), and disciplined SG&A management is structurally improving fixed cost leverage and expected to yield improved net margins and earnings power as sales volumes recover.
Ongoing construction of a new R&D center and increased R&D investment is expected to accelerate the rollout of premium, environmentally friendly, and specialty coatings that command higher price points, supporting future gross margin expansion and increasing competitive differentiation as sustainability and performance requirements intensify.
Want to see what kind of revenue path, margin lift, and earnings profile it takes to justify that higher fair value? The most followed narrative leans on steady top line progress, fatter margins, and a richer earnings multiple than the wider chemicals group to make the numbers work, all under a specific discount rate that quietly does a lot of heavy lifting.
Result: Fair Value of $388.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on demand not remaining weak for an extended period and on Sherwin-Williams effectively managing supply chain and fixed cost pressures that could further compress margins.
Find out about the key risks to this Sherwin-Williams narrative.
Another Way To Look At Sherwin-Williams’ Valuation
So far, the focus has been on cash flow based fair value estimates that suggest Sherwin-Williams is trading below intrinsic value. The earnings multiple tells a different story, with a current P/E of 30.3x versus a fair ratio of 24.8x and an industry average of 29.2x.
That gap implies you are paying more per dollar of earnings than the fair ratio points to, even if peers and the broader Chemicals group sit in a similar range. The key question is whether Sherwin-Williams’ execution, balance sheet and earnings quality justify sticking closer to 30x earnings, or if the market could drift toward that lower fair ratio over time.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals on valuation and guidance in mind, it makes sense to look at the full picture yourself and decide what truly matters for your portfolio. To weigh up both sides of the story, go straight to the 3 key rewards and 1 important warning sign
Looking for more investment ideas?
If Sherwin-Williams is already on your radar, consider using this momentum to broaden your opportunity set and compare it with other focused ideas across sectors and styles.
- Spot potential value opportunities early by reviewing companies highlighted in the screener containing 25 high quality undiscovered gems.
- Prioritise resilience and support peace of mind by checking out stocks featured in the 68 resilient stocks with low risk scores.
- Focus on financial strength first by scanning companies screened in the solid balance sheet and fundamentals stocks screener (40 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com